INVITRO BIOSYNTHESIS OF COMPLEMENT FACTOR-I BY HUMAN ENDOTHELIAL-CELLS

被引:37
作者
JULEN, N
DAUCHEL, H
LEMERCIER, C
SIM, RB
FONTAINE, M
RIPOCHE, J
机构
[1] UNIV OXFORD, DEPT BIOCHEM, MRC, IMMUNOCHEM UNIT, OXFORD, ENGLAND
[2] INSERM, U78, BOIS GUILLAUME, FRANCE
关键词
D O I
10.1002/eji.1830220131
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have studied the secretion of the complement regulatory protein factor I by human umbilical vein endothelial cells (HUVEC). Northern and Western blot analysis and biosynthetic labeling experiments indicate that HUVEC secrete factor I at very low levels in basal conditions and that this secretion is significantly enhanced by interferon-gamma. Analysis of the proteolytic inactivation of C3b by HUVEC supernatants show that factor I is secreted in a functional form and can promote the specific proteolytic inactivation of C3b to iC3b. Together with previous studies establishing the secretion of complement factor H by HUVEC, this work demonstrates that the endothelial cell is able to secrete in its environment two complement regulatory proteins, factor I and factor H, which can mediate the degradation of C3b to iC3b. The secretion of factor I by HUVEC provides a useful in vitro model to analyze the modulation of this secretion and may be relevant to the local deposition of iC3b at the surface of the endothelium during the inflammatory reaction.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 32 条
[1]   PURIFICATION OF COMPLEMENT COMPONENTS BY HYDROPHOBIC AFFINITY-CHROMATOGRAPHY ON PHENYL SEPHAROSE - PURIFICATION OF HUMAN C5 [J].
ALSALIHI, A ;
RIPOCHE, J ;
PRUVOST, L ;
FONTAINE, M .
FEBS LETTERS, 1982, 150 (01) :238-242
[2]   DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
ASCH, AS ;
KINOSHITA, T ;
JAFFE, EA ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) :221-226
[3]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[4]   POTENTIATION OF FACTOR-H BY HEPARIN - A RATE-LIMITING MECHANISM FOR INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY [J].
BOACKLE, RJ ;
CAUGHMAN, GB ;
VESELY, J ;
MEDGYESI, G ;
FUDENBERG, HH .
MOLECULAR IMMUNOLOGY, 1983, 20 (11) :1157-1164
[5]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[6]  
BROOIMANS RA, 1990, J IMMUNOL, V144, P3835
[7]   CHARACTERIZATION OF THE PRIMARY AMINO-ACID-SEQUENCE OF HUMAN-COMPLEMENT CONTROL PROTEIN FACTOR-I FROM AN ANALYSIS OF CDNA CLONES [J].
CATTERALL, CF ;
LYONS, A ;
SIM, RB ;
DAY, AJ ;
HARRIS, TJR .
BIOCHEMICAL JOURNAL, 1987, 242 (03) :849-856
[8]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[9]   EXPRESSION OF COMPLEMENT ALTERNATIVE PATHWAY PROTEINS BY ENDOTHELIAL-CELLS - DIFFERENTIAL REGULATION BY INTERLEUKIN-1 AND GLUCOCORTICOIDS [J].
DAUCHEL, H ;
JULEN, N ;
LEMERCIER, C ;
DAVEAU, M ;
OZANNE, D ;
FONTAINE, M ;
RIPOCHE, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (08) :1669-1675
[10]   LOCAL OPSONIZATION BY SECRETED MACROPHAGE COMPLEMENT COMPONENTS - ROLE OF RECEPTORS FOR COMPLEMENT IN UPTAKE OF ZYMOSAN [J].
EZEKOWITZ, RAB ;
SIM, RB ;
HILL, M ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :244-260